Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone involvement in idiopathic calcium lithiasis]

A Ghazali1, P Bataille, M C Solal

  • 1Service de néphrologie, médecine interne, CHU, Amiens.

Nephrologie
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation.

The Journal of pharmacology and experimental therapeutics·1992
Same author

Studies of 300-microns microcapsules: I. Use of arginine esterase release by microencapsulated prostatic cells as a measure of membrane permeability.

Transplantation proceedings·1992
Same author

Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.

The Journal of pharmacology and experimental therapeutics·1992
Same author

Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.

The Journal of pharmacology and experimental therapeutics·1992
Same author

Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein.

Brain research·1992
Same author

Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.

Kidney international·1992

Idiopathic calcium nephrolithiasis can cause decreased bone density and impaired bone formation, particularly in hypercalciuric patients. These bone abnormalities are linked to hypercalciuria type and may involve altered cytokine synthesis and vitamin D metabolism.

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Biology

Context:

  • Idiopathic calcium nephrolithiasis (kidney stones) is frequently associated with bone abnormalities.
  • Bone density and histology are affected, with severity correlating to hypercalciuria type.

Purpose:

  • To characterize bone involvement in idiopathic calcium nephrolithiasis.
  • To explore the relationship between hypercalciuria, bone metabolism, and potential contributing factors.

Summary:

  • Bone density decreases in hypercalciuric stone formers, with severity dependent on hypercalciuria type.
  • Bone histology reveals impaired bone formation, with increased resorption markers suggesting altered bone remodeling.
  • Hypercalciuria may be linked to altered calcitriol synthesis and cytokine profiles, impacting bone cell function.

Related Experiment Videos

Impact:

  • Understanding these bone complications is crucial for managing hypercalciuric stone formers.
  • This research highlights potential therapeutic targets for preventing bone loss in this patient group.